David Edwards
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David Edwards has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Catherine Coombes
2 shared publicationsD. Jon Barnett
2 shared publications- Mark R. Battle
GE Healthcare, Amersham United Kingdom
2 shared publications Rochelle Lear
2 shared publicationsVanessa Godden
2 shared publications- Aaron M. Ellison
Department of Organismic and Evolutionary Biology Harvard University Herbaria, Harvard University Cambridge MA 02138 USA
1 shared publication
Latest Publications
- Open Access
- 21 August 2025
- Published by Taylor & Francis in Landscape Research
- Vol. 51 (5) , 1-19
What do indeterminacy and uncertainty mean in landscape research? Perspectives from natural sciences, social sciences, and arts
- 21 August 2025
- Published by Taylor & Francis in Landscape Research
- Vol. 51 (5) , 1-19
Open AccessWhat do indeterminacy and uncertainty mean in landscape research? Perspectives from natural sciences, social sciences, and arts
- Open Access
- 2 March 2018
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10574, 87
Tapering analysis of airways with bronchiectasis
Bronchiectasis is the permanent dilation of airways. Patients with the disease can suffer recurrent exacerbations, reducing their quality of life. The gold standard to diagnose and monitor bronchiectasis is accomplished by inspection of chest computed tomography (CT) scans. A clinician examines the broncho-arterial ratio to determine if an airway is brochiectatic. The visual analysis assumes the blood vessel diameter remains constant, although this assumption is disputed in the literature. We propose a simple measurement of tapering along the airways to diagnose and monitor bronchiectasis. To this end, we constructed a pipeline to measure the cross-sectional area along the airways at contiguous intervals, starting from the carina to the most distal point observable. Using a phantom with calibrated 3D printed structures, the precision and accuracy of our algorithm extends to the sub voxel level. The tapering measurement is robust to bifurcations along the airway and was applied to chest CT images acquired in clinical practice. The result is a statistical difference in tapering rate between airways with bronchiectasis and controls.
- 2 March 2018
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10574, 87
Open AccessTapering analysis of airways with bronchiectasis
Bronchiectasis is the permanent dilation of airways. Patients with the disease can suffer recurrent exacerbations, reducing their quality of life. The gold standard to diagnose and monitor bronchiectasis is accomplished by inspection of chest computed tomography (CT) scans. A clinician examines the broncho-arterial ratio to determine if an airway is brochiectatic. The visual analysis assumes the blood vessel diameter remains constant, although this assumption is disputed in the literature. We propose a simple measurement of tapering along the airways to diagnose and monitor bronchiectasis. To this end, we constructed a pipeline to measure the cross-sectional area along the airways at contiguous intervals, starting from the carina to the most distal point observable. Using a phantom with calibrated 3D printed structures, the precision and accuracy of our algorithm extends to the sub voxel level. The tapering measurement is robust to bifurcations along the airway and was applied to chest CT images acquired in clinical practice. The result is a statistical difference in tapering rate between airways with bronchiectasis and controls.
- Open Access
- 30 December 2008
- Published by Herpetological Society of Japan in Current Herpetology
- Vol. 27 (2) , 109-112
Calotes versicolor (Squamata: Agamidae)-A New Invasive Squamate for Borneo
- 30 December 2008
- Published by Herpetological Society of Japan in Current Herpetology
- Vol. 27 (2) , 109-112
Open AccessCalotes versicolor (Squamata: Agamidae)-A New Invasive Squamate for Borneo
- Open Access
- 17 October 2007
- Published by Springer Nature in Nature
- Vol. 449 (7164) , 789
Science in culture: Paris gets a new cultural crucible
- 17 October 2007
- Published by Springer Nature in Nature
- Vol. 449 (7164) , 789
Open AccessScience in culture: Paris gets a new cultural crucible
- 1 January 2007
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 28 (1) , 55-62
99mTc-NC100668, an agent for imaging venous thromboembolism: The effect of anticoagulant or thrombolytic therapy on the uptake and retention of radioactivity in blood clots in vivo
The purpose of this study was to evaluate the uptake of (99m)Tc-NC100668 into blood clots and elucidate the potential for medications commonly used to treat thromboembolism to interfere with the uptake and retention of (99m)Tc-NC100668. (99m)Tc-NC100668 in vivo uptake and retention in a range of blood clot of various ages (up to 4 h. old) and in the presence of anticoagulants or thrombolytic therapies was measured in a rat model of deep vein thrombosis. (99m)Tc-NC100668 was rapidly absorbed into and retained by blood clots and was not significantly affected by the presence of unfractionated or low molecular weight heparin or thrombin inhibitor. Tissue plasminogen activator reduced the uptake of (99m)Tc-NC100668 into blood clot by a factor of 3 when adjusted to allow for changes in the weight of the blood clot. This study has demonstrated that the uptake and retention of (99m)Tc-NC100668 into blood clots in the rat model of deep vein thrombosis is rapid and maintained over at least a 4 h. post-injection period. It has been shown that (99m)Tc-NC100668 is retained in blood clots even in the presence of therapeutic doses of those anticoagulant and thrombolytic therapies typically used to treat pulmonary embolism and venous thrombosis.
- 1 January 2007
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 28 (1) , 55-62
99mTc-NC100668, an agent for imaging venous thromboembolism: The effect of anticoagulant or thrombolytic therapy on the uptake and retention of radioactivity in blood clots in vivo
The purpose of this study was to evaluate the uptake of (99m)Tc-NC100668 into blood clots and elucidate the potential for medications commonly used to treat thromboembolism to interfere with the uptake and retention of (99m)Tc-NC100668. (99m)Tc-NC100668 in vivo uptake and retention in a range of blood clot of various ages (up to 4 h. old) and in the presence of anticoagulants or thrombolytic therapies was measured in a rat model of deep vein thrombosis. (99m)Tc-NC100668 was rapidly absorbed into and retained by blood clots and was not significantly affected by the presence of unfractionated or low molecular weight heparin or thrombin inhibitor. Tissue plasminogen activator reduced the uptake of (99m)Tc-NC100668 into blood clot by a factor of 3 when adjusted to allow for changes in the weight of the blood clot. This study has demonstrated that the uptake and retention of (99m)Tc-NC100668 into blood clots in the rat model of deep vein thrombosis is rapid and maintained over at least a 4 h. post-injection period. It has been shown that (99m)Tc-NC100668 is retained in blood clots even in the presence of therapeutic doses of those anticoagulant and thrombolytic therapies typically used to treat pulmonary embolism and venous thrombosis.
- Open Access
- 1 July 2006
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 34 (7) , 1128-1135
THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
99mTc-NC100668 [Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-Tyr(3-iodo)-Thr-Leu-Leu-Lys-Gly-NC100194] is a radiopharmaceutical imaging agent being developed to aid the diagnosis of thromboembolism. The stability profile of 99mTc-NC100668 was investigated by high-performance liquid chromatography (HPLC) after in vitro exposure to blood and plasma obtained from rat and human, as well as to urine and bile obtained from rat. The metabolic profile of 99mTc-NC100668 exposed to human and rat hepatic S9 (a liver homogenate-rich cytochrome P450) was also studied. The profile of 99mTc-labeled species in plasma, urine, and bile was investigated following i.v. administration of 99mTc-NC100668 to rat. The major species observed in vitro and in vivo consisted of the 99mTc-chelator (NC100194) [N,N-Bis(N-(1,1-dimethyl-2-(hydroxylimino-)propyl)aminoethyl)aminoethylamine] attached to the C-terminal amino acid residue and referred to as 99mTc-complex of Gly-NC100194. The identity of the major metabolite was confirmed by cochromatography with an authentic standard and the genuine metabolite using a second HPLC method. The minor metabolites were sodium pertechnetate (99mTc) and 99mTc-NC100194. In addition, a small number of other species were transiently observed in vitro; they were not investigated further. The biodistribution of the major metabolite was studied in male Wistar rats. The affinity of the major metabolite toward plasma clot was established using a plasma clot-forming assay. A minor uptake of 99mTc-complex of Gly-NC100194 in the plasma clot and a rapid removal from the body were noted. In conclusion, the metabolites of 99mTc-NC100668 are not anticipated to have a negative impact on the ability of the test substance to image blood clots.
- 1 July 2006
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 34 (7) , 1128-1135
Open AccessTHE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
99mTc-NC100668 [Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-Tyr(3-iodo)-Thr-Leu-Leu-Lys-Gly-NC100194] is a radiopharmaceutical imaging agent being developed to aid the diagnosis of thromboembolism. The stability profile of 99mTc-NC100668 was investigated by high-performance liquid chromatography (HPLC) after in vitro exposure to blood and plasma obtained from rat and human, as well as to urine and bile obtained from rat. The metabolic profile of 99mTc-NC100668 exposed to human and rat hepatic S9 (a liver homogenate-rich cytochrome P450) was also studied. The profile of 99mTc-labeled species in plasma, urine, and bile was investigated following i.v. administration of 99mTc-NC100668 to rat. The major species observed in vitro and in vivo consisted of the 99mTc-chelator (NC100194) [N,N-Bis(N-(1,1-dimethyl-2-(hydroxylimino-)propyl)aminoethyl)aminoethylamine] attached to the C-terminal amino acid residue and referred to as 99mTc-complex of Gly-NC100194. The identity of the major metabolite was confirmed by cochromatography with an authentic standard and the genuine metabolite using a second HPLC method. The minor metabolites were sodium pertechnetate (99mTc) and 99mTc-NC100194. In addition, a small number of other species were transiently observed in vitro; they were not investigated further. The biodistribution of the major metabolite was studied in male Wistar rats. The affinity of the major metabolite toward plasma clot was established using a plasma clot-forming assay. A minor uptake of 99mTc-complex of Gly-NC100194 in the plasma clot and a rapid removal from the body were noted. In conclusion, the metabolites of 99mTc-NC100668 are not anticipated to have a negative impact on the ability of the test substance to image blood clots.
- 1 August 1999
- Published by Elsevier in Meat Science
- Vol. 52 (4) , 387-389
High voltage electrical stimulation: its effect on microbial contamination of lamb carcases in a commercial abattoir
- 1 August 1999
- Published by Elsevier in Meat Science
- Vol. 52 (4) , 387-389
High voltage electrical stimulation: its effect on microbial contamination of lamb carcases in a commercial abattoir
- 1 October 1994
- Published by Oxford University Press (OUP) in Botanical Journal of the Linnean Society
- Vol. 116 (2) , 89-110
Lower Devonian coalified sporangia from Shropshire: Salopella Edwards & Richardson and Tortilicaulis Edwards
- 1 October 1994
- Published by Oxford University Press (OUP) in Botanical Journal of the Linnean Society
- Vol. 116 (2) , 89-110
Lower Devonian coalified sporangia from Shropshire: Salopella Edwards & Richardson and Tortilicaulis Edwards